american diabetes association 'history of pancreatitis' glp-1 receptor agonist glucagon-like peptide-1 agonists with cardiovascular and kidney outcomes in type 2 diabetic kidney transplant recipients | Cardiovascular Diabetology Pancreatitis Risk Associated with GLP-1
Description
What role does whole-person wellness play in achieving lasting results
Substantial variability emerged among individual agents: exenatide demonstrated the longest median latency (54 days, IQR 16184), while dulaglutide showed the shortest (7 days, IQR 234)
Little information informs the potential actions of amylin in the human cardiovascular system
No statistically significant link, but still worth monitoring , especially in symptomatic patients
